Publicaciones en colaboración con investigadores/as de Massachusetts General Hospital (13)

2013

  1. Effect of elevated pulmonary vascular resistance on outcomes after percutaneous mitral valvuloplasty

    American Journal of Cardiology, Vol. 112, Núm. 4, pp. 580-584

2011

  1. Difference in outcome among women and men after percutaneous mitral valvuloplasty

    Catheterization and Cardiovascular Interventions, Vol. 77, Núm. 1, pp. 115-120

2010

  1. Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction

    Diabetes Research and Clinical Practice, Vol. 88, Núm. 1, pp. 97-102

2009

  1. Heparin-Induced Thrombocytopenia

    Pharmacology in the Catheterization Laboratory (Wiley-Blackwell), pp. 261-269

  2. Impact of Pre- and Postprocedural Mitral Regurgitation on Outcomes After Percutaneous Mitral Valvuloplasty for Mitral Stenosis

    American Journal of Cardiology, Vol. 104, Núm. 8, pp. 1122-1127

  3. Left atrial appendage exclusion using an Amplatzer device

    International Journal of Cardiology, Vol. 134, Núm. 1

  4. Predicting Success and Long-Term Outcomes of Percutaneous Mitral Valvuloplasty: A Multifactorial Score

    American Journal of Medicine, Vol. 122, Núm. 6

2008

  1. Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome

    Journal of Thrombosis and Thrombolysis, Vol. 25, Núm. 2, pp. 214-218

  2. Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction: Molecular Diagnosis

    Journal of Cellular and Molecular Medicine, Vol. 12, Núm. 3, pp. 955-961

  3. Impact of concomitant aortic regurgitation on percutaneous mitral valvuloplasty: Immediate results, short-term, and long-term outcome

    American Heart Journal, Vol. 156, Núm. 2, pp. 361-366

  4. What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?

    Blood Coagulation and Fibrinolysis, Vol. 19, Núm. 5, pp. 401-404

2007

  1. Anaphylaxis and recurrent hydatid disease

    Circulation, Vol. 115, Núm. 25

  2. Heparin-induced thrombocytopenia

    Revista Espanola de Cardiologia, Vol. 60, Núm. 10, pp. 1071-1082